Muriel Bouly

1.2k total citations
20 papers, 1.1k citations indexed

About

Muriel Bouly is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Muriel Bouly has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Muriel Bouly's work include Peroxisome Proliferator-Activated Receptors (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Heart rate and cardiovascular health (5 papers). Muriel Bouly is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Heart rate and cardiovascular health (5 papers). Muriel Bouly collaborates with scholars based in France, Italy and Germany. Muriel Bouly's co-authors include Bart Staels, Jean‐Charles Fruchart, Gérald Luc, B Dupuis, Patrick Gelé, Patrick Duriez, Dominique Deplanque, Stéphane Nion, Roméo Cecchelli and Didier Leys and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Neuroscience.

In The Last Decade

Muriel Bouly

20 papers receiving 1.1k citations

Peers

Muriel Bouly
Byung Yong Rhim South Korea
Haruki Yamakawa Japan
Eva Chou United States
Giuseppe Cifelli Italy
Yumei Zhan Japan
Bo-Wen Lin China
Ashay D. Bhatwadekar United States
Xunde Xian China
Nobuyo Maeda United States
Kerrie J. Way Australia
Byung Yong Rhim South Korea
Muriel Bouly
Citations per year, relative to Muriel Bouly Muriel Bouly (= 1×) peers Byung Yong Rhim

Countries citing papers authored by Muriel Bouly

Since Specialization
Citations

This map shows the geographic impact of Muriel Bouly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Bouly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Bouly more than expected).

Fields of papers citing papers by Muriel Bouly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Bouly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Bouly. The network helps show where Muriel Bouly may publish in the future.

Co-authorship network of co-authors of Muriel Bouly

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Bouly. A scholar is included among the top collaborators of Muriel Bouly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Bouly. Muriel Bouly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakraborty, Praloy, Stéphane Massé, Mohammed Ali Azam, et al.. (2022). Effects of azumolene on arrhythmia substrate in a model of recurrent long-duration ventricular fibrillation. Biochemical and Biophysical Research Communications. 600. 123–129. 3 indexed citations
2.
Hackenbroch, Carsten, et al.. (2022). What Is Normal for an Aging Heart?: A Prospective CMR Cohort Study. PubMed. 30(3). 202–202. 13 indexed citations
3.
Bouly, Muriel, Willy Gosgnach, Nicolas Diguet, et al.. (2021). Aging increases circulating BH2 without modifying BH4 levels and impairs peripheral vascular function in healthy adults. Translational research. 238. 36–48. 8 indexed citations
4.
Nicol, Lionel, Isabelle Rémy‐Jouet, Anaïs Dumesnil, et al.. (2017). The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure. JACC Basic to Translational Science. 2(4). 418–430. 54 indexed citations
5.
Dai, Wangde, Robert A. Kloner, Jianru Shi, et al.. (2017). Effect of Diabetes on Myocardial Infarct and No Reflow Size in an Experimental Rat Model and Clinical Trial. Journal of Clinical & Experimental Cardiology. 8(12). 1 indexed citations
6.
7.
Suffredini, Silvia, Francesca Stillitano, Laura Comini, et al.. (2011). Long‐term treatment with ivabradine in post‐myocardial infarcted rats counteracts f‐channel overexpression. British Journal of Pharmacology. 165(5). 1457–1466. 54 indexed citations
8.
Busseuil, David, Yanfen Shi, Marc‐Antoine Gillis, et al.. (2010). Heart Rate Reduction by Ivabradine Reduces Diastolic Dysfunction and Cardiac Fibrosis. Cardiology. 117(3). 234–242. 57 indexed citations
9.
Ceconi, Claudio, Laura Comini, Silvia Suffredini, et al.. (2010). Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 300(1). H366–H373. 48 indexed citations
10.
Santina, Luca Della, et al.. (2010). Effect of HCN Channel Inhibition on Retinal Morphology and Function in Normal and Dystrophic Rodents. Investigative Ophthalmology & Visual Science. 51(2). 1016–1016. 18 indexed citations
11.
Ceconi, Claudio, Laura Comini, Silvia Suffredini, et al.. (2007). Abstract 316: Heart Rate Reduction Prevents The Global Phenotype Of Post-myocardial LV Infarction Remodeling. Circulation. 116. 1 indexed citations
12.
Mahlberg‐Gaudin, Florence, et al.. (2005). Pharmacological Basics of ƒ-Current Inhibition. 5(1). 14–20. 2 indexed citations
13.
Luc, Gérald, Nelly Jacob, Muriel Bouly, et al.. (2004). Fenofibrate Increases Homocystinemia Through a PPARα-Mediated Mechanism. Journal of Cardiovascular Pharmacology. 43(3). 452–453. 24 indexed citations
14.
Mardones, Pablo, Antoine Pilon, Muriel Bouly, et al.. (2003). Fibrates Down-regulate Hepatic Scavenger Receptor Class B Type I Protein Expression in Mice. Journal of Biological Chemistry. 278(10). 7884–7890. 108 indexed citations
15.
Deplanque, Dominique, Patrick Gelé, Olivier Pétrault, et al.. (2003). Peroxisome Proliferator-Activated Receptor-α Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment. Journal of Neuroscience. 23(15). 6264–6271. 195 indexed citations
16.
Deplanque, Dominique, Patrick Gelé, Olivier Pétrault, et al.. (2003). Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.. PubMed. 23(15). 6264–71. 215 indexed citations
17.
Bouly, Muriel, David Masson, Barbara Gross, et al.. (2001). Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate. Journal of Biological Chemistry. 276(28). 25841–25847. 78 indexed citations
18.
Deplanque, Dominique, Patrick Gelé, Muriel Bouly, et al.. (2000). Increase in brain superoxide dismutase as a potential mechanism of peroxisome proliferator-activated receptor alpha activator-induced brain ischemic tolerance. 70531. 1 indexed citations
19.
Tailleux, Anne, Muriel Bouly, Gérald Luc, et al.. (2000). Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice. Arteriosclerosis Thrombosis and Vascular Biology. 20(11). 2453–2458. 46 indexed citations
20.
Esposito, Bruno, Muriel Bouly, Nicole Delhaye‐Bouchaud, et al.. (1998). Severe Atherosclerosis and Hypoalphalipoproteinemia in the Staggerer Mouse, a Mutant of the Nuclear Receptor RORα. Circulation. 98(24). 2738–2743. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Byung Yong Rhim Breakdown of academic impact, for papers by Haruki Yamakawa Breakdown of academic impact, for papers by Eva Chou Breakdown of academic impact, for papers by Giuseppe Cifelli Breakdown of academic impact, for papers by Yumei Zhan Breakdown of academic impact, for papers by Bo-Wen Lin Breakdown of academic impact, for papers by Ashay D. Bhatwadekar Breakdown of academic impact, for papers by Xunde Xian Breakdown of academic impact, for papers by Nobuyo Maeda Breakdown of academic impact, for papers by Kerrie J. Way
Rankless by CCL
2026